Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2004) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Trends in Pharmacological Sciences | journal | 3.825 Q1 | 244 | 117 | 489 | 5609 | 3267 | 392 | 7.46 | 47.94 |  |
| 2 | Clinical Pharmacokinetics | journal | 1.578 Q1 | 184 | 73 | 250 | 6098 | 1586 | 246 | 6.53 | 83.53 | |
| 3 | Nature Reviews Drug Discovery | journal | 8.115 Q1 | 391 | 317 | 492 | 7006 | 3213 | 170 | 6.53 | 22.10 | |
| 4 | Neuropsychopharmacology | journal | 2.241 Q1 | 249 | 250 | 659 | 13878 | 3291 | 620 | 4.75 | 55.51 | |
| 5 | Expert Opinion on Investigational Drugs | journal | 1.078 Q1 | 117 | 136 | 644 | 11132 | 2222 | 621 | 4.21 | 81.85 | |
| 6 | Drug Safety | journal | 1.211 Q1 | 140 | 94 | 264 | 6299 | 1152 | 253 | 4.12 | 67.01 | |
| 7 | Neuropharmacology | journal | 1.901 Q1 | 191 | 261 | 696 | 13239 | 2861 | 696 | 4.03 | 50.72 | |
| 8 | Current Opinion in Drug Discovery and Development | journal | 1.182 Q1 | 85 | 78 | 269 | 4338 | 911 | 252 | 3.77 | 55.62 | |
| 9 | Journal of Antimicrobial Chemotherapy | journal | 1.435 Q1 | 221 | 465 | 1265 | 11630 | 4622 | 1023 | 3.72 | 25.01 | |
| 10 | Antiviral Therapy | journal | 1.624 Q1 | 93 | 118 | 164 | 4626 | 633 | 157 | 3.67 | 39.20 | |
| 11 | Pharmacogenomics Journal | journal | 1.284 Q1 | 95 | 58 | 174 | 2214 | 586 | 150 | 3.35 | 38.17 | |
| 12 | Receptors and Channels | journal | 1.369 Q1 | 44 | 19 | 92 | 868 | 279 | 85 | 3.28 | 45.68 | |
| 13 | Current Opinion in Molecular Therapeutics | journal | 1.175 Q1 | 67 | 87 | 263 | 4579 | 816 | 240 | 3.20 | 52.63 | |
| 14 | International Journal of Neuropsychopharmacology | journal | 1.338 Q1 | 125 | 70 | 155 | 2716 | 476 | 138 | 2.95 | 38.80 | |
| 15 | Molecular Diagnosis and Therapy | journal | 68 | 68 | 170 | 3725 | 393 | 167 | 2.68 | 54.78 | | |
| 16 | Current Opinion in Investigational Drugs | journal | 0.780 Q2 | 83 | 158 | 449 | 7594 | 1156 | 418 | 2.66 | 48.06 | |
| 17 | PharmacoEconomics | journal | 0.907 Q1 | 118 | 121 | 318 | 5062 | 947 | 307 | 2.65 | 41.83 | |
| 18 | Expert Opinion on Therapeutic Targets | journal | 0.930 Q1 | 106 | 54 | 162 | 4953 | 365 | 155 | 2.60 | 91.72 | |
| 19 | Expert Opinion on Biological Therapy | journal | 0.928 Q1 | 102 | 170 | 292 | 13679 | 799 | 280 | 2.59 | 80.46 | |
| 20 | British Journal of Clinical Pharmacology | journal | 0.904 Q2 | 167 | 219 | 590 | 5397 | 1657 | 516 | 2.57 | 24.64 | |
| 21 | Pharmacogenomics | journal | 0.933 Q1 | 100 | 98 | 219 | 4704 | 572 | 188 | 2.56 | 48.00 | |
| 22 | BioDrugs | journal | 0.737 Q2 | 79 | 35 | 172 | 3364 | 468 | 167 | 2.25 | 96.11 | |
| 23 | Drug Discovery Today | journal | 0.851 Q2 | 215 | 380 | 1073 | 8164 | 2199 | 833 | 2.23 | 21.48 | |
| 24 | Journal of Psychopharmacology | journal | 0.923 Q1 | 135 | 81 | 188 | 3428 | 463 | 173 | 2.17 | 42.32 | |
| 25 | Fundamental and Clinical Pharmacology | journal | 0.583 Q2 | 85 | 80 | 185 | 2852 | 344 | 181 | 2.05 | 35.65 | |
| 26 | Expert Review of Vaccines | journal | 0.642 Q2 | 105 | 105 | 135 | 5673 | 275 | 125 | 2.04 | 54.03 | |
| 27 | Expert Opinion on Pharmacotherapy | journal | 0.535 Q2 | 93 | 230 | 532 | 15724 | 1093 | 516 | 2.00 | 68.37 | |
| 28 | Xenobiotica | journal | 0.703 Q2 | 89 | 73 | 242 | 2773 | 518 | 240 | 1.90 | 37.99 | |
| 29 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.314 Q3 | 25 | 0 | 40 | 0 | 57 | 30 | 1.89 | 0.00 | |
| 30 | Antiviral Chemistry and Chemotherapy | journal | 0.599 Q2 | 59 | 33 | 106 | 1284 | 226 | 106 | 1.80 | 38.91 | |
| 31 | Clinical and Experimental Pharmacology and Physiology | journal | 0.773 Q2 | 115 | 180 | 550 | 5535 | 1054 | 545 | 1.80 | 30.75 | |
| 32 | Chemical Biology and Drug Design | journal | 0.685 | 91 | 79 | 250 | 2611 | 422 | 246 | 1.73 | 33.05 | |
| 33 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.697 Q2 | 57 | 44 | 129 | 1924 | 230 | 115 | 1.72 | 43.73 | |
| 34 | BMC Pharmacology | journal | 0.520 Q2 | 48 | 32 | 50 | 1245 | 81 | 50 | 1.65 | 38.91 | |
| 35 | Journal of Peptide Science | journal | 0.575 Q2 | 73 | 75 | 208 | 2688 | 325 | 201 | 1.62 | 35.84 | |
| 36 | Journal of Pharmacy and Pharmacology | journal | 0.582 Q2 | 137 | 205 | 624 | 7080 | 1097 | 619 | 1.54 | 34.54 | |
| 37 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.442 Q3 | 92 | 79 | 185 | 2309 | 252 | 184 | 1.53 | 29.23 | |
| 38 | Journal of Antibiotics | journal | 0.773 Q2 | 92 | 112 | 440 | 1752 | 647 | 368 | 1.45 | 15.64 | |
| 39 | Expert Opinion on Therapeutic Patents | journal | 0.488 Q2 | 88 | 117 | 383 | 6244 | 521 | 375 | 1.42 | 53.37 | |
| 40 | Reviews in Contemporary Pharmacotherapy | journal | 0.557 Q2 | 18 | 1 | 11 | 854 | 16 | 11 | 1.40 | 854.00 | |
| 41 | Expert Opinion on Emerging Drugs | journal | 0.389 Q3 | 54 | 25 | 86 | 2887 | 110 | 83 | 1.37 | 115.48 | |
| 42 | BMC Clinical Pharmacology | journal | 0.897 Q2 | 43 | 6 | 16 | 212 | 33 | 16 | 1.33 | 35.33 | |
| 43 | American Journal of Respiratory Medicine | journal | 0.343 Q3 | 34 | 0 | 93 | 0 | 120 | 87 | 1.29 | 0.00 | |
| 44 | Phytotherapy Research | journal | 0.549 Q2 | 158 | 214 | 600 | 5213 | 823 | 598 | 1.23 | 24.36 | |
| 45 | Biopharmaceutics and Drug Disposition | journal | 0.492 Q2 | 65 | 48 | 124 | 1039 | 199 | 123 | 1.20 | 21.65 | |
| 46 | Journal of Immune Based Therapies and Vaccines | journal | 0.264 Q3 | 21 | 9 | 5 | 367 | 6 | 4 | 1.20 | 40.78 | |
| 47 | Biomedical Chromatography | journal | 0.531 Q2 | 71 | 126 | 241 | 2708 | 286 | 238 | 1.19 | 21.49 | |
| 48 | ChemMedChem | journal | 0.435 | 119 | 134 | 470 | 3524 | 595 | 468 | 1.19 | 26.30 | |
| 49 | Journal of Chemotherapy | journal | 0.367 Q3 | 56 | 174 | 375 | 3554 | 465 | 340 | 1.19 | 20.43 | |
| 50 | Acta Pharmacologica Sinica | journal | 0.386 Q3 | 117 | 260 | 640 | 5907 | 713 | 640 | 1.18 | 22.72 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data